Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

News Trending Portfolio

TOOLS

Top Insiders Stocks

Top Smart Score Stocks

STOCKS

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

Best Cannabis & Marijuana Stocks

Best cannabis & marijuana stocks for 2023. Cannabis is a plant that can be used to treat, manage, or improve medical symptoms. It is also used for recreational purposes, given its psychoactive properties. Also known as marijuana, weed, and other names, it has become legal or decriminalized in most U.S. states, Canada, and other places. Consumers are becoming more accepting of cannabis, appreciating its medicinal and recreational properties. This has led to a slew of companies that research, develop, and distribute medical and recreational marijuana. As a result, the marijuana industry is projected to double in value by 2025, making it popular with investors. This list covers the best cannabis companies.

Compare up to 10 stocks

CGC MO ABBV SMG JAZZ HEXO CURLF GTBIF TCNNF

Comparison Results

Name	Price	Price Change	Volume	Market Cap	Analyst Price Target	Analyst Consensus	Smart Score	Article	Follow
CGC Canopy Growth	$7.30	$0.14 (1.96%)	2.29M	$735.19M	xxxxxxxxxxxxx	1 Buy 5 Hold 2 Sell Hold
MO Altria Group	$50.43	$0.63 (1.27%)	7.00M	$85.54B	xxxxxxxxxxxxx	2 Buy 2 Hold 2 Sell Hold
ABBV AbbVie	$185.16	$2.99 (1.64%)	6.95M	$321.69B	xxxxxxxxxxxxx	12 Buy 3 Hold 0 Sell Strong Buy
SMG Scotts Miracle-Gro Company	$70.61	$2.29 (3.35%)	1.08M	$3.88B	xxxxxxxxxxxxx	2 Buy 3 Hold 0 Sell Moderate Buy
JAZZ Jazz Pharmaceuticals	$111.57	$2.03 (1.85%)	645.16K	$6.91B	xxxxxxxxxxxxx	12 Buy 2 Hold 0 Sell Strong Buy
CURLF Curaleaf Holdings	$4.03	$0.06 (1.51%)	126.65K	$2.96B	xxxxxxxxxxxxx	5 Buy 0 Hold 0 Sell Strong Buy
GTBIF Green Thumb Industries	$11.24	$0.07 (0.63%)	96.85K	$2.63B	xxxxxxxxxxxxx	7 Buy 0 Hold 0 Sell Strong Buy
TCNNF Trulieve Cannabis	$10.05	$0.12 (1.21%)	159.72K	$1.89B	xxxxxxxxxxxxx	7 Buy 0 Hold 0 Sell Strong Buy
HEXO	―	―	―	―	xxxxxxxxxxxxx	―

Performance Comparison

CGC

Canopy Growth

7.16

3.06

74.63%

MO

Altria Group

49.80

8.09

19.40%

ABBV

AbbVie

182.17

38.86

27.12%

SMG

Scotts Miracle-Gro Company

68.32

2.34

3.55%

JAZZ

Jazz Pharmaceuticals

109.54

-20.63

-15.85%

HEXO

―

―

―

―

CURLF

Curaleaf Holdings

3.97

0.73

22.53%

GTBIF

Green Thumb Industries

11.17

4.52

67.97%

TCNNF

Trulieve Cannabis

9.93

5.98

151.39%

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Cannabis Stocks Latest News

Curaleaf Expands Retail Presence in New York

Curaleaf Expands Retail Presence in New York

Curaleaf Holdings (TSE:CURA) has released an update. Curaleaf Holdings is broadening its reach in New York with the...

9h ago

Canopy Growth Unveils Q1 2025 Financial Results Date

Canopy Growth Unveils Q1 2025 Financial Results Date

Canopy Growth (TSE:WEED) has released an update. Canopy Growth Corporation has announced it will present its Q1 Fiscal...

14h ago

SPY ETF Update, 7/26/2024

SPY ETF Update, 7/26/2024 

How is SPY stock faring? The SPDR S&P 500 ETF Trust  is down 2.64% in the past 5 days...

19h ago

Rising High: Exclusive talk with software developer Rank Really High

Rising High: Exclusive talk with software developer Rank Really High

In this edition of “Rising High,” The Fly conducted an exclusive interview with Dan Mondello, Co-Founder and Chief...

1d ago

ABBV Earnings: AbbVie Exceeds Q2 Expectations Driven by Strong Immunology Sales

ABBV Earnings: AbbVie Exceeds Q2 Expectations Driven by Strong Immunology Sales

AbbVie ($ABBV) reported strong results for the second quarter. The company announced adjusted diluted earnings of $2.65 per...

1d ago

AbbVie sees FY24 revenue approximately $55.5B, consensus $50.87B

AbbVie sees FY24 revenue approximately $55.5B, consensus $50.87B

09:40 EDT AbbVie sees FY24 revenue approximately $55.5B, consensus $50.87B Published first on TheFly – the ultimate source...

2d ago

AbbVie sees FY24 gross margin 84% of sales

AbbVie sees FY24 gross margin 84% of sales

Sees non-GAAP tax rate 16.3%. Sees FY24 Skyrizi revenue $11B, Rinvoq revenue $5.7B. Published first on TheFly –...

2d ago

AbbVie sees Q3 adjusted EPS $2.92-$2.96, consensus $2.68

AbbVie sees Q3 adjusted EPS $2.92-$2.96, consensus $2.68

Sees Q3 revenue $14.2B, consensus $13.06B. Published first on TheFly – the ultimate source for real-time, market-moving breaking...

2d ago

AbbVie: Discontinuing development of ABBV-916 as standalone antibody

AbbVie: Discontinuing development of ABBV-916 as standalone antibody

09:25 EDT AbbVie: Discontinuing development of ABBV-916 as standalone antibody Published first on TheFly – the ultimate source...

2d ago

AbbVie ‘confident’ in long-term growth outlook for aesthetics group

AbbVie ‘confident’ in long-term growth outlook for aesthetics group

09:14 EDT AbbVie ‘confident’ in long-term growth outlook for aesthetics group Published first on TheFly – the ultimate...

2d ago

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Cannabis Stocks

AbbVie

Buy

Reiterated

2024-07-26

Jazz Pharmaceuticals

Buy

Reiterated

2024-07-25

Scotts Miracle-Gro Company

Hold

Reiterated

2024-07-23

Altria Group

Buy

Assigned

2024-07-18

Canopy Growth

Sell

Reiterated

2024-07-09

Trulieve Cannabis

Buy

Assigned

2024-06-11

Curaleaf Holdings

Buy

Reiterated

2024-05-20

Green Thumb Industries

Buy

Reiterated

2024-05-20

AbbVie

Buy

Reiterated

2024-07-26

AbbVie

Buy

Assigned

2024-07-26

Most Recent Earnings of Cannabis Stocks

Canopy Growth

May 30, 2024

Mar 01, 2024

-0.32 / -0.75

-0.507

Altria Group

Apr 25, 2024

Mar 01, 2024

1.15 / 1.15

1.31

AbbVie

Jul 25, 2024

Jun 01, 2024

2.57 / 2.65

2.95

Scotts Miracle-Gro Company

May 01, 2024

Mar 01, 2024

3.44 / 3.69

1.17

Jazz Pharmaceuticals

May 01, 2024

Mar 01, 2024

4.18 / 2.68

4.51

Curaleaf Holdings

May 09, 2024

Mar 01, 2024

-0.06 / -0.07

-0.065

Green Thumb Industries

May 08, 2024

Mar 01, 2024

0.05 / 0.13

0.036

Trulieve Cannabis

May 09, 2024

Mar 01, 2024

-0.10 / -0.12

-1.549

HEXO

―

―

―

- / -

―

Cannabis Stocks - FAQ

Which Cannabis stocks have a "Strong Buy" analyst rating?

These Cannabis stocks currently have a "Strong Buy" analyst rating consensus:

AbbVie - Strong Buy, based on 15 analyst ratings, 12 Buy, 3 Hold, and 0 Sell.

Jazz Pharmaceuticals - Strong Buy, based on 14 analyst ratings, 12 Buy, 2 Hold, and 0 Sell.

Curaleaf Holdings - Strong Buy, based on 5 analyst ratings, 5 Buy, 0 Hold, and 0 Sell.

Green Thumb Industries - Strong Buy, based on 7 analyst ratings, 7 Buy, 0 Hold, and 0 Sell.

Trulieve Cannabis - Strong Buy, based on 7 analyst ratings, 7 Buy, 0 Hold, and 0 Sell.

Are Cannabis stocks overpriced?

Canopy Growth's stock price is currently $7.30, and its average 12-month price target is $6.63.

Altria Group's stock price is currently $50.43, and its average 12-month price target is $43.63.

AbbVie's stock price is currently $185.16, and its average 12-month price target is $193.79.

Scotts Miracle-Gro Company's stock price is currently $70.61, and its average 12-month price target is $74.25.

Jazz Pharmaceuticals's stock price is currently $111.57, and its average 12-month price target is $177.83.

Curaleaf Holdings's stock price is currently $4.03, and its average 12-month price target is $9.11.

Green Thumb Industries's stock price is currently $11.24, and its average 12-month price target is $20.36.

Trulieve Cannabis's stock price is currently $10.05, and its average 12-month price target is $17.88.

's stock price is currently N/A, and its average 12-month price target is N/A.

Which Cannabis stocks pay dividends?

Canopy Growth does not currently pay dividends.

Altria Group does not currently pay dividends.

AbbVie does not currently pay dividends.

Scotts Miracle-Gro Company does not currently pay dividends.

Jazz Pharmaceuticals does not currently pay dividends.

Curaleaf Holdings does not currently pay dividends.

Green Thumb Industries does not currently pay dividends.

Trulieve Cannabis does not currently pay dividends.

does not currently pay dividends.